141 related articles for article (PubMed ID: 38009625)
1. Clinical features of non-classical 21-hydroxylase deficiency after normal newborn mass screening.
Takahashi F; Adachi S; Sakurai N; Mori T; Fujikura K; Usui T; Hasegawa T
Pediatr Int; 2023; 65(1):e15674. PubMed ID: 38009625
[No Abstract] [Full Text] [Related]
2. Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology
Horm Res; 2001; 55(4):201-5. PubMed ID: 11598375
[TBL] [Abstract][Full Text] [Related]
3. Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods.
Podgórski R; Aebisher D; Stompor M; Podgórska D; Mazur A
Acta Biochim Pol; 2018; 65(1):25-33. PubMed ID: 29543924
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
Kopacek C; Prado MJ; da Silva CMD; de Castro SM; Beltrão LA; Vargas PR; Grandi T; Rossetti MLR; Spritzer PM
J Pediatr (Rio J); 2019; 95(3):282-290. PubMed ID: 29715434
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the degree of clinical suspect in patients with congenital adrenal hyperplasia by 21-hydroxylase deficiency before obtaining the result of the newborn screening program of the autonomous Community of Madrid.].
Sanz Fernández M; Mora Sitja M; Carrascón González Pinto L; Rodríguez Sánchez A
Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33372915
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for congenital adrenal hyperplasia in Wisconsin.
Allen DB
Wis Med J; 1993 Feb; 92(2):75-8. PubMed ID: 8451862
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of neonatal screening for congenital adrenal hyperplasia.
Honour JW; Torresani T
Horm Res; 2001; 55(4):206-11. PubMed ID: 11598376
[TBL] [Abstract][Full Text] [Related]
9. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in neonatal mass screening for congenital hypothyroidism and adrenal hyperplasia using enzyme immunoassays.
Tsuji A; Maeda M; Arakawa H
Adv Clin Chem; 1990; 28():109-43. PubMed ID: 2077875
[No Abstract] [Full Text] [Related]
11. False negatives at neonatal screening for congenital adrenal hyperplasia in two siblings with 21-hydroxylase deficiency.
Shinohara O; Ishiguro H; Shinagawa T; Kubota C
Endocr J; 1998 Jun; 45(3):427-30. PubMed ID: 9790280
[TBL] [Abstract][Full Text] [Related]
12. High 17-hydroxyprogesterone level in newborn screening test for congenital adrenal hyperplasia.
Levy-Shraga Y; Pinhas-Hamiel O
BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26912766
[TBL] [Abstract][Full Text] [Related]
13. A pilot study for neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase and 11-beta-hydroxylase deficiency in Campania region.
Valentino R; Tommaselli AP; Rossi R; Lombardi G; Varrone S
J Endocrinol Invest; 1990 Mar; 13(3):221-5. PubMed ID: 2365957
[TBL] [Abstract][Full Text] [Related]
14. The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives.
de Hora M; Heather N; Webster D; Albert B; Hofman P
Front Endocrinol (Lausanne); 2023; 14():1226284. PubMed ID: 37850096
[TBL] [Abstract][Full Text] [Related]
15. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
[TBL] [Abstract][Full Text] [Related]
16. Congenital adrenal hyperplasia: diagnostic advances.
Torresani T; Biason-Lauber A
J Inherit Metab Dis; 2007 Aug; 30(4):563-75. PubMed ID: 17694353
[TBL] [Abstract][Full Text] [Related]
17. Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency - the next disease included in the neonatal screening program in Poland.
Ginalska-Malinowska M
Dev Period Med; 2018; 22(2):197-200. PubMed ID: 30056407
[TBL] [Abstract][Full Text] [Related]
18. Congenital adrenal hyperplasia and violation of newborn screening procedures.
Odajima H; Hosono S; Kayama K; Yoshikawa K; Takahashi S
Pediatr Int; 2017 Oct; 59(10):1107-1108. PubMed ID: 28960615
[No Abstract] [Full Text] [Related]
19. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
20. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Fujieda K; Mukai T
Nihon Rinsho; 2004 Feb; 62(2):361-7. PubMed ID: 14968546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
